Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04034173
Title Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ludwig-Maximilians - University of Munich

colon adenocarcinoma

rectum adenocarcinoma


Fluorouracil + Irinotecan + Leucovorin + Panitumumab

Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST